Trial
NCT04028713
Dose Tapering Study of Adalimumab in Psoriasis
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University Hospital, Ghent
Collaborators
KU Leuven; University Ghent
Condition
Psoriasis Vulgaris
Intervention
Venapuncture
Why stopped
Too slow inclusion rate.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-09-19